Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial ...

Combination immune checkpoint inhibitor therapy (ICI) with ipilimumab (anti–cytotoxic T-lymphocyte–associated protein 4) + nivolumab (anti–PD-1) in untreated, metastatic melanoma has achieved a ...

Substantial improvements in childhood cancer survival rates have resulted in a growing population of survivors who are living longer. Unfortunately, these survivors carry a substantial burden of ...

Over the past two decades, monoclonal antibodies (mAbs) have played a pivotal role in cancer treatment; however, their efficacy as anticancer agents is constrained by tumor heterogeneity and the ...

Cancer clinical trials represent a critical mechanism to advance the fields of hematology and oncology. Every US Food and Drug Administration (FDA)-approved cancer treatment has made its way through ...

We would like to compliment Samnani et al 1 on their insightful evaluation of the impact of the IDEA studies on real-world practice. As requested in the accompanied editorial, 2 we hereby would like ...

Since sorafenib's approval in 2008 for advanced HCC, the landscape of systemic therapy remained largely unchanged for nearly a decade, with no breakthroughs emerging during this period. However, in ...

This two-arm prospective phase III open-label trial randomly assigns (1:1) participants with low–tumor burden FL who wish to pursue active management to rituximab versus mosunetuzumab (Fig 1), ...

Risk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2 Neu–Negative Invasive Breast Cancer This ...

Survivorship Care for People Affected by Advanced or Metastatic Cancer: Building on the Recent Multinational Association of Supportive Care in Cancer-ASCO Standards and Practice Recommendations The ...

The field of rare cancer research is rapidly transforming, marked by significant progress in clinical trials and treatment strategies. Rare cancers, as defined by the National Cancer Institute, occur ...

Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial The initial data set was compiled ...